Study Evaluating Safety and Tolerability of Vabicaserin in Patients With Sudden Worsening of Schizophrenia
Clinical trial NCT00768612 · WITHDRAWN
Trial details
- NCT number
- NCT00768612
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2009-07-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.